Rafael Holdings Inc
RFL1.749USD
-0.001-0.04%
Market hours （ET）Quotes delayed by 15 min
56.83MMarket Cap
LossP/E TTM
More Details of Rafael Holdings Inc Company
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. It holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in Cornerstone Pharmaceuticals, Inc. (a cancer metabolism-based therapeutics company). It holds a majority interest in Rafael Medical Devices, LLC., an orthopedic-focused medical device company, and a majority interest in Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their cannabis offerings enabling them to bring to market predictable versions by utilizing Day Three's pharmaceutical-grade technology and innovation like Unlokt. Its investments include Cyclo Therapeutics Inc. (developing Trappsol Cyclo). It holds a portion of a commercial building in Israel.
Company Info
Ticker SymbolRFL
Company nameRafael Holdings Inc
IPO dateMar 12, 2018
CEOMr. Howard S. Jonas
Number of employees28
Security typeOrdinary Share
Fiscal year-endMar 12
Address520 Broad Street
CityNEWARK
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code07120
Phone12126581450
Websitehttps://rafaelholdings.com
Ticker SymbolRFL
IPO dateMar 12, 2018
CEOMr. Howard S. Jonas
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Howard S. Jonas
Mr. Howard S. Jonas
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
13.90M
+1592.51%
Dr. Michael J. Weiss, M.D., Ph.D.
Dr. Michael J. Weiss, M.D., Ph.D.
Independent Director
Independent Director
102.48K
--
Mr. Stephen M. Greenberg
Mr. Stephen M. Greenberg
Lead Independent Director
Lead Independent Director
10.25K
-90.00%
Dr. John M. Goldberg, M.D.
Dr. John M. Goldberg, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. N. Scott Fine
Mr. N. Scott Fine
Non-Executive Vice Chairman of the Board
Non-Executive Vice Chairman of the Board
--
--
Mr. Mark N. Stein
Mr. Mark N. Stein
Independent Director
Independent Director
--
--
Mr. Markus Walter Sieger
Mr. Markus Walter Sieger
Independent Director
Independent Director
--
--
Mr. David A. Polinsky
Mr. David A. Polinsky
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Susan Bernstein
Ms. Susan Bernstein
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Howard S. Jonas
Mr. Howard S. Jonas
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
13.90M
+1592.51%
Dr. Michael J. Weiss, M.D., Ph.D.
Dr. Michael J. Weiss, M.D., Ph.D.
Independent Director
Independent Director
102.48K
--
Mr. Stephen M. Greenberg
Mr. Stephen M. Greenberg
Lead Independent Director
Lead Independent Director
10.25K
-90.00%
Dr. John M. Goldberg, M.D.
Dr. John M. Goldberg, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. N. Scott Fine
Mr. N. Scott Fine
Non-Executive Vice Chairman of the Board
Non-Executive Vice Chairman of the Board
--
--
Mr. Mark N. Stein
Mr. Mark N. Stein
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Aug 1
Updated: Fri, Aug 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jonas (Howard S)
40.53%
i9 PLUS, L.L.C.
10.54%
The Vanguard Group, Inc.
2.92%
Conkling (William)
1.65%
Dimensional Fund Advisors, L.P.
0.99%
Other
43.37%
Shareholders
Shareholders
Proportion
Jonas (Howard S)
40.53%
i9 PLUS, L.L.C.
10.54%
The Vanguard Group, Inc.
2.92%
Conkling (William)
1.65%
Dimensional Fund Advisors, L.P.
0.99%
Other
43.37%
Shareholder Types
Shareholders
Proportion
Individual Investor
45.18%
Corporation
10.54%
Investment Advisor
5.69%
Investment Advisor/Hedge Fund
2.12%
Family Office
0.70%
Venture Capital
0.61%
Hedge Fund
0.15%
Research Firm
0.12%
Other
34.90%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
93
21.42M
62.44%
+12.97M
2025Q1
98
8.17M
28.85%
-61.05K
2024Q4
90
7.29M
30.39%
-660.45K
2024Q3
94
7.39M
31.07%
-354.11K
2024Q2
109
7.56M
31.85%
-1.78M
2024Q1
142
7.38M
31.10%
-2.82M
2023Q4
152
7.68M
32.41%
-2.73M
2023Q3
187
7.52M
31.90%
-4.47M
2023Q2
197
7.66M
32.47%
-4.19M
2023Q1
207
7.48M
31.71%
-4.31M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jonas (Howard S)
13.90M
40.53%
+13.08M
+1592.51%
Jun 05, 2025
i9 PLUS, L.L.C.
3.62M
10.54%
+390.63K
+12.11%
Jun 05, 2025
The Vanguard Group, Inc.
1.00M
2.92%
+301.18K
+42.89%
Mar 31, 2025
Conkling (William)
564.46K
1.65%
+12.64K
+2.29%
Mar 25, 2025
Dimensional Fund Advisors, L.P.
338.43K
0.99%
--
--
Mar 31, 2025
Polinsky (David)
268.07K
0.78%
-2.35K
-0.87%
Jun 21, 2025
Geode Capital Management, L.L.C.
260.96K
0.76%
+86.40K
+49.50%
Mar 31, 2025
IEQ Capital LLC
238.88K
0.7%
+238.88K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
217.79K
0.63%
+25.81K
+13.45%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
Dimensional US Core Equity 1 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
